แข้งเจลีก
Status: ~~ ♡. (° ο°)~
: 0 ใบ
: 0 ใบ
เข้าร่วม: 31 Oct 2014
ตอบ: 6509
ที่อยู่: LONDON
โพสเมื่อ: Thu Jul 22, 2021 08:29
[RE: Sinopharm vs Delta variant (ผลการทดลอง)]
ถือว่า โอเคนะ
20 to 39 years (98.9%). 81.25% had ACE2 receptor blocking antibodies at 6 weeks, and there was no difference in these antibody titres in vaccine sera compared to convalescent sera (p=0.44). Vaccinees had significantly less (p<0.0001) antibodies to the RBD of WT and B.1.1.7, although there was no difference in antibodies to the RBD of B.1.351 and B.1.617.2 compared to convalescent sera. 27.7% of 46.4% of vaccinees had ex vivo IFNγ and cultured ELISpot responses respectively, and IFNγ and CD107a responses were detected by flow cytometry
แก้ไขล่าสุดโดย champzaa8 เมื่อ Thu Jul 22, 2021 08:31, ทั้งหมด 1 ครั้ง